Follow-up care experience of patients with invasive meningococcal disease and their family caregivers: a qualitative study.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
19 Sep 2024
Historique:
received: 02 02 2024
accepted: 02 09 2024
medline: 20 9 2024
pubmed: 20 9 2024
entrez: 19 9 2024
Statut: epublish

Résumé

Clinical guidelines recommend systematic follow-up of patients surviving invasive meningococcal disease (IMD) to assess sequelae. However, little is known about survivors and family caregivers' experiences of the follow-up care. Study sought to explore IMD survivors' and their family caregivers' experiences after hospitalization for IMD and to identify unmet needs. Semi-structured interviews were conducted with patients and family caregivers, identified through hospitals database. Interviews were audiotaped, transcribed and subject to a thematic analysis. NVivo software was used for data management and analysis. Eight IMD survivors and 14 family caregivers were interviewed. Three themes were identified from the data: (1) perception of patient and family caregiver on follow-up after IMD and role of healthcare professionals; (2) access to care and support; (3) relationship with healthcare professionals. Although most were satisfied with follow-up care after IMD, suggestions for improving the healthcare pathway were made relating information on potential sequelae and follow-up care, coordination, and access to psychological support. This study confirms the need for more structured follow-up care for patients suffering from IMD and their families which is currently limited and focused on physical recovery. Optimal follow-up should aim to provide sufficient information, emotional support and logistical support for patient and family caregivers. Ethics Committee of University of Lyon, France (ref: 2022-06-23-002).

Sections du résumé

BACKGROUND BACKGROUND
Clinical guidelines recommend systematic follow-up of patients surviving invasive meningococcal disease (IMD) to assess sequelae. However, little is known about survivors and family caregivers' experiences of the follow-up care. Study sought to explore IMD survivors' and their family caregivers' experiences after hospitalization for IMD and to identify unmet needs.
METHODS METHODS
Semi-structured interviews were conducted with patients and family caregivers, identified through hospitals database. Interviews were audiotaped, transcribed and subject to a thematic analysis. NVivo software was used for data management and analysis.
RESULTS RESULTS
Eight IMD survivors and 14 family caregivers were interviewed. Three themes were identified from the data: (1) perception of patient and family caregiver on follow-up after IMD and role of healthcare professionals; (2) access to care and support; (3) relationship with healthcare professionals. Although most were satisfied with follow-up care after IMD, suggestions for improving the healthcare pathway were made relating information on potential sequelae and follow-up care, coordination, and access to psychological support.
CONCLUSIONS CONCLUSIONS
This study confirms the need for more structured follow-up care for patients suffering from IMD and their families which is currently limited and focused on physical recovery. Optimal follow-up should aim to provide sufficient information, emotional support and logistical support for patient and family caregivers.
TRIAL REGISTRATION BACKGROUND
Ethics Committee of University of Lyon, France (ref: 2022-06-23-002).

Identifiants

pubmed: 39300360
doi: 10.1186/s12879-024-09860-6
pii: 10.1186/s12879-024-09860-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1002

Informations de copyright

© 2024. The Author(s).

Références

WHO. Meningococcus. In: Overview: Vaccine Preventable Diseases Surveillance Standards. edn.; 2018 15.
Koomen I, Raat H, Jennekens-Schinkel A, Grobbee DE, Roord JJ, van Furth M. Academic and behavioral limitations and health-related quality of life in school-age survivors of bacterial meningitis. Qual Life Res. 2005;14(6):1563–72.
doi: 10.1007/s11136-004-7706-z pubmed: 16110936
Duval X, Taha MK, Lamaury I, Escaut L, Gueit I, Manchon P, Tubiana S, Hoen B. Group cs: one-year sequelae and quality of life in adults with meningococcal meningitis: lessons from the COMBAT Multicentre prospective study. Adv Ther. 2022;39(6):3031–41.
doi: 10.1007/s12325-022-02149-7 pubmed: 35484469 pmcid: 9123035
Viner RM, Booy R, Johnson H, Edmunds WJ, Hudson L, Bedford H, Kaczmarski E, Rajput K, Ramsay M, Christie D. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol. 2012;11(9):774–83.
doi: 10.1016/S1474-4422(12)70180-1 pubmed: 22863608
Buysse CM, Raat H, Hazelzet JA, Hop WC, Maliepaard M, Joosten KF. Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge. Crit Care Med. 2008;36(2):596–602.
doi: 10.1097/01.CCM.0000299740.65484.CA pubmed: 18216608
Ehrlich TR, Von Rosenstiel IA, Grootenhuis MA, Gerrits AI, Bos AP. Long-term psychological distress in parents of child survivors of severe meningococcal disease. Pediatr Rehabil. 2005;8(3):220–4.
doi: 10.1080/13638490400022246 pubmed: 16087557
WHO. Defeating meningitis by 2030: a global road map. World Health Organization; 2021.
Hoen B, Varon E, de Debroucker T, Fantin B, Grimprel E, Wolff M, Duval X. Expert, reviewing g: management of acute community-acquired bacterial meningitis (excluding newborns). Long version with arguments. Med Mal Infect. 2019;49(6):405–41.
doi: 10.1016/j.medmal.2019.03.009 pubmed: 31402154
Borg J, Christie D, Coen PG, Booy R, Viner RM. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics. 2009;123(3):e502–509.
doi: 10.1542/peds.2008-0581 pubmed: 19254985
Briand C, Levy C, Baumie F, Joao L, Bechet S, Carbonnelle E, Grimprel E, Cohen R, Gaudelus J, de Pontual L. Outcomes of bacterial meningitis in children. Med Mal Infect. 2016;46(4):177–87.
doi: 10.1016/j.medmal.2016.02.009 pubmed: 27020729
Clark LJ, Glennie L, Audrey S, Hickman M, Trotter CL. The health, social and educational needs of children who have survived meningitis and septicaemia: the parents’ perspective. BMC Public Health. 2013;13:954.
doi: 10.1186/1471-2458-13-954 pubmed: 24112360 pmcid: 3852620
Sweeney F, Viner RM, Booy R, Christie D. Parents’ experiences of support during and after their child’s diagnosis of meningococcal disease. Acta Paediatr. 2013;102(3):e126–130.
doi: 10.1111/apa.12112 pubmed: 23205710
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.
doi: 10.1093/intqhc/mzm042 pubmed: 17872937
DeJonckheere MA-O, Vaughn LM. Semistructured interviewing in primary care research: a balance of relationship and rigour. (2305–6983 (Print)).
Pyo J, Lee W, Choi EY, Jang SG, Ock M. Qualitative Research in Healthcare: necessity and characteristics. J Prev Med Public Health. 2023;56(1):12–20.
doi: 10.3961/jpmph.22.451 pubmed: 36746418 pmcid: 9925284
Chafe R. The Value of Qualitative Description in Health Services and Policy Research. Healthc Policy. 2017;12(3):12–8.
pubmed: 28277201 pmcid: 5344360
Smith J, Bekker H, Cheater F. Theoretical versus pragmatic design in qualitative research. Nurse Res. 2011;18(2):39–51.
doi: 10.7748/nr2011.01.18.2.39.c8283 pubmed: 21319483
Bradshaw C, Atkinson S, Doody O. Employing a qualitative description Approach in Health Care Research. Glob Qual Nurs Res. 2017;4:2333393617742282.
pubmed: 29204457 pmcid: 5703087
Braun V, Clarke V. What can thematic analysis offer health and wellbeing researchers? Int J Qual Stud Health Well-being. 2014;9:26152.
doi: 10.3402/qhw.v9.26152 pubmed: 25326092
McIntosh MJ, Morse JM. Situating and constructing diversity in Semi-structured interviews. Glob Qual Nurs Res. 2015;2:2333393615597674.
pubmed: 28462313 pmcid: 5342650
Ruslin, Mashuri S, Sarib M, Rasak A, Alhabsyi F, Syam H. Semi-structured interview: a methodological reflection on the development of a qualitative research instrument in Educational studies. IOSR J Res Method Educ. 2022;12:22–9.
Lincoln YS, Guba EG. But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. New Dir Program Evaluation. 1986;1986(30):73–84.
doi: 10.1002/ev.1427
Forero RA-O, Nahidi S, De Costa J, Mohsin M, Fitzgerald G, Gibson N, McCarthy S, Aboagye-Sarfo P. Application of four-dimension criteria to assess rigour of qualitative research in emergency medicine. (1472–6963 (Electronic)).
Boateng EA, Agyapomah R, Amankwaa I, Dzomeku VM, Peprah LO. Perspectives of Family caregivers on Healthcare provided to older adults with hypertension and/or diabetes Mellitus in Ghana. Gerontol Geriatr Med. 2024;10:23337214241261534.
doi: 10.1177/23337214241261534 pubmed: 38899054 pmcid: 11186387
McInnes S, Peters K, Bonney A, Halcomb E. An exemplar of naturalistic inquiry in general practice research. Nurse Res. 2017;24(3):36–41.
doi: 10.7748/nr.2017.e1509 pubmed: 28102791
Korstjens I, Moser A. Series: practical guidance to qualitative research. Part 4: trustworthiness and publishing. Eur J Gen Pract. 2018;24(1):120–4.
doi: 10.1080/13814788.2017.1375092 pubmed: 29202616
Huang L, Heuer OD, Janssen S, Hackl D, Schmedt N. Clinical and economic burden of invasive meningococcal disease: evidence from a large German claims database. PLoS ONE. 2020;15(1):e0228020.
doi: 10.1371/journal.pone.0228020 pubmed: 31990941 pmcid: 6986746
Weil-Olivier C, Taha MK, Emery C, Bouee S, Beck E, Aris E, Loncle-Provot V, Nachbaur G, Pribil C. Healthcare Resource Consumption and cost of Invasive Meningococcal Disease in France: a study of the National Health Insurance Database. Infect Dis Ther. 2021;10(3):1607–23.
doi: 10.1007/s40121-021-00468-w pubmed: 34170505 pmcid: 8322339
Wang B, Haji Ali Afzali H, Marshall H. The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children. Vaccine. 2014;32(37):4791–8.
doi: 10.1016/j.vaccine.2014.05.069 pubmed: 24998605
Huang L, Fievez S, Goguillot M, Marie L, Benard S, Elkaim A, Tin Tin Htar M. A database study of clinical and economic burden of invasive meningococcal disease in France. PLoS ONE. 2022;17(4):e0267786.
doi: 10.1371/journal.pone.0267786 pubmed: 35486581 pmcid: 9053794
Davis KL, Misurski D, Miller JM, Bell TJ, Bapat B. Cost of acute hospitalization and post-discharge follow-up care for meningococcal disease in the US. Hum Vaccin. 2011;7(1):96–101.
doi: 10.4161/hv.7.1.13692 pubmed: 21278486
Haines C. Parents’ experiences of living through their child’s suffering from and surviving severe meningococcal disease. Nurs Crit Care. 2005;10(2):78–89.
doi: 10.1111/j.1362-1017.2005.00080.x pubmed: 15839239
Bruchon-Schweitzer M, Boujut É. Les modèles en psychologie de la santé: un état des lieux. Psychologie De La santé. edn. Paris: Dunod; 2014. pp. 525–42.
doi: 10.3917/dunod.bruch.2014.01.0525
Hummelinck A, Pollock K. Parents’ information needs about the treatment of their chronically ill child: a qualitative study. Patient Educ Couns. 2006;62(2):228–34.
doi: 10.1016/j.pec.2005.07.006 pubmed: 16139981
Cacioppo JT, Cacioppo S, Petty RE. The neuroscience of persuasion: A review with an emphasis on issues and opportunities. (1747 – 0927 (Electronic)).
Olbrich KJ, Muller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on patients and their caregivers. Infect Dis Ther. 2018;7(4):421–38.
doi: 10.1007/s40121-018-0213-2 pubmed: 30267220 pmcid: 6249177
Shen J, Begum N, Ruiz-Garcia Y, Martinon-Torres F, Bekkat-Berkani R, Meszaros K. Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review. BMC Public Health. 2022;22(1):1078.
doi: 10.1186/s12889-022-13342-2 pubmed: 35641955 pmcid: 9153861
Wisemantel M, Maple M, Massey P, Osbourn M, Kohlhagen J. Psychosocial challenges of Invasive Meningococcal Disease for Children and their families. Australian Social Work 2018, 71(4).
Scanferla E, Gorwood P, Fasse L. Familial experience of acute bacterial meningitis in children: a transversal qualitative study using interpretative phenomenological analysis. BMJ Open. 2021;11(7):e047465.
doi: 10.1136/bmjopen-2020-047465 pubmed: 34285009 pmcid: 8292830
McMillan M, McDonough J, Angliss M, Buttery J, Saunders L, Mathew SM, Shaw D, Gordon D, Warner MS, Nelson R et al. Exploring the Health-Related Quality of Life and the lived experience of adolescents following invasive meningococcal disease. Healthc (Basel) 2024, 12(11).

Auteurs

Alexiane Baloche (A)

Health Systemic Process (P2S), Unit Research UR4129, University Claude Bernard Lyon 1, University of Lyon, Lyon, France. alexiane.baloche@univ-lyon1.fr.
Univ. Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France. alexiane.baloche@univ-lyon1.fr.
Health Systematic Process (P2S), Unit Research UR4129, Faculté de médecine Laënnec, 7-11 Rue Guillaume Paradin, Lyon, 69371, CEDEX 08, France. alexiane.baloche@univ-lyon1.fr.

Pierrick Bedouch (P)

Univ. Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France.
Univ. Grenoble Alpes, CNRS, Pharmacy Department, CHU Grenoble Alpes, Grenoble INP, TIMC, Grenoble, France.

Florence Carrouel (F)

Health Systemic Process (P2S), Unit Research UR4129, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.

Laurent Argaud (L)

Medical Intensive Care Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.

Karine Kolev (K)

Hospices Civils de Lyon, Paediatric Intensive Care Unit, Mothers and Children University Hospital, Bron, France.

Guillaume Mortamet (G)

Univ. Grenoble Alpes, Pediatric Intensive Care Unit, CHU Grenoble Alpes, Grenoble, France.

Carole Schwebel (C)

Univ. Grenoble Alpes, Department of Medical ICU, CHU Grenoble Alpes, Grenoble, France.

Gérard Mick (G)

Health Systemic Process (P2S), Unit Research UR4129, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.
Univ. Grenoble Alpes, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, TIMC, Grenoble, France.
CETD du Voironnais, CHU Grenoble Alpes, Grenoble, France.

Claude Dussart (C)

Health Systemic Process (P2S), Unit Research UR4129, University Claude Bernard Lyon 1, University of Lyon, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH